Welcome to our dedicated page for ACMAT news (Ticker: ACMT), a resource for investors and traders seeking the latest updates and insights on ACMAT stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ACMAT's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ACMAT's position in the market.
AM Best has affirmed a Long-Term Issuer Credit Rating of “bbb” for ACMAT Corporation (ACMT) and an A (Excellent) rating for its subsidiary, ACSTAR Insurance Company. The outlook for both ratings is stable, driven by ACSTAR's strong balance sheet and enterprise risk management. However, the ratings reflect a notable decline in premium volume due to management's selectivity in a competitive market and the impact of COVID-19 on construction delays. Despite this, AM Best anticipates improved opportunities from recent infrastructure legislation.
FAQ
What is the market cap of ACMAT (ACMT)?
